tiprankstipranks
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
US Market

Allarity Therapeutics, Inc. (ALLR) Income Statement

Compare
249 Followers

Allarity Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Allarity Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Allarity Therapeutics, Inc.'s net income was $-12.15M. See Allarity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 120.00K
Gross Profit
$ -37.00K$ -120.00K$ -106.00K$ -86.00K$ 120.00K
Operating Expenses
$ 17.89M$ 16.89M$ 26.56M$ 9.23M$ 10.24M
Depreciation and Amortization
$ 37.00K$ 120.00K$ 106.00K$ 86.00K$ 85.00K
EBITDA
$ -12.08M$ -17.24M$ -25.91M$ -6.01M$ -15.58M
Operating Income
$ -17.93M$ -34.46M$ -26.56M$ -9.23M$ -17.61M
Other Income/Expenses
$ 5.31M$ -687.00K$ 41.00K$ 1.90M$ -8.86M
Pretax Income
$ -12.62M$ -17.58M$ -26.52M$ -7.23M$ -18.98M
Net Income
$ -11.90M$ -16.06M$ -26.65M$ -5.07M$ -14.40M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.01$ -1.86M$ -3.52M$ -1.70M$ -189.61K
Diluted EPS
$ -0.01$ -1.86M$ -3.52M$ -1.70M$ -189.61K
Weighted Average Shares Outstanding
1.99B----
Weighted Average Shares Outstanding (Diluted)
1.99B----
Currency in USD

Allarity Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis